| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |